In our analysis, Josephin Domain-containing protein 2 (JOSD2) stood out as its high expression was significantly correlated with poor prognosis of NSCLC patients and depletion of JOSD2 posed most potent inhibitory effects on NSCLC cell growth. Here, JOSD2 is linked to non-small cell lung carcinoma.